Neuregulin 1 represses limbic epileptogenesis through ErbB4 in parvalbumin-expressing interneurons

Nature Neuroscience

Volumn 15, Issue 2, 2012, Pages 258-266

  Tan, Guo He ^a   Liu, Yuan Yuan ^a   Hu, Xiao Ling ^a   Yin, Dong Min ^b   Mei, Lin ^b   Xiong, Zhi Qi ^a  

^a INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

^b MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 4; NEU DIFFERENTIATION FACTOR; PARVALBUMIN; REPRESSOR PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COMPLEX PARTIAL SEIZURE; CONTROLLED STUDY; DISEASE COURSE; DISEASE EXACERBATION; EPILEPTOGENESIS; FEEDBACK SYSTEM; GENE DELETION; INTERNEURON; INTRACELLULAR SIGNALING; KINDLING; MALE; MOSSY FIBER; MOUSE; NERVE SPROUTING; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PYRAMIDAL NERVE CELL; RAT; UPREGULATION;

ANALYSIS OF VARIANCE; ANIMALS; ANTICONVULSANTS; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASE TYPE 2; DIAZEPAM; DISEASE MODELS, ANIMAL; ELECTROENCEPHALOGRAPHY; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPILEPSY; ESTROGEN ANTAGONISTS; INTERNEURONS; KINDLING, NEUROLOGIC; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MUSCARINIC AGONISTS; MUSCARINIC ANTAGONISTS; NEUREGULIN-1; ORGANIC CHEMICALS; PARVALBUMINS; PILOCARPINE; PYRIMIDINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, EPIDERMAL GROWTH FACTOR; SCOPOLAMINE HYDROBROMIDE; TAMOXIFEN; TIME FACTORS; UP-REGULATION;

EID: 84856245459     PISSN: 10976256     EISSN: 15461726     Source Type: Journal    
DOI: 10.1038/nn.3005     Document Type: Article

References (49)

1. Morimoto, K., Fahnestock, M. & Racine, R.J. Kindling and status epilepticus models of epilepsy: rewiring the brain. Prog. Neurobiol. 73, 1-60 (2004). (Pubitemid 38749090)
2. Hauser, W.A., Annegers, J.F. & Kurland, L.T. Incidence of epilepsy and unprovoked seizures in Rochester, Minnesota: 1935-1984. Epilepsia 34, 453-468 (1993). (Pubitemid 23184580)
3. McNamara, J.O., Huang, Y.Z. & Leonard, A.S. Molecular signaling mechanisms underlying epileptogenesis. Sci. STKE 2006, re12 (2006).
4. Duncan, J.S., Sander, J.W., Sisodiya, S.M. & Walker, M.C. Adult epilepsy. Lancet 367, 1087-1100 (2006).
5. Rice, A.C. & DeLorenzo, R.J. Kindling induces long-term changes in gene expression. in. Kindling 5 (eds. Corcoran, M. & Moshe, S.) 267-284 (Plenum, 1998).
6. Delorenzo, R.J. & Morris, T.A. Long-term modulation of gene expression in epilepsy. Neuroscientist 5, 86-99 (1999). (Pubitemid 29114264)
7. Hughes, P.E. et al. Activity and injury-dependent expression of inducible transcription factors, growth factors and apoptosis-related genes within the central nervous system. Prog. Neurobiol. 57, 421-450 (1999). (Pubitemid 29057111)
8. Binder, D.K., Routbort, M.J., Ryan, T.E., Yancopoulos, G.D. & McNamara, J.O. Selective inhibition of kindling development by intraventricular administration of TrkB receptor body. J. Neurosci. 19, 1424-1436 (1999). (Pubitemid 29088924)
9. He, X.P. et al. Conditional deletion of TrkB but not BDNF prevents epileptogenesis in the kindling model. Neuron 43, 31-42 (2004).
10. Mei, L. & Xiong, W.C. Neuregulin 1 in neural development, synaptic plasticity and schizophrenia. Nat. Rev. Neurosci. 9, 437-452 (2008). (Pubitemid 351704944)
11. Steiner, H., Blum, M., Kitai, S.T. & Fedi, P. Differential expression of ErbB3 and ErbB4 neuregulin receptors in dopamine neurons and forebrain areas of the adult rat. Exp. Neurol. 159, 494-503 (1999). (Pubitemid 29485235)
12. Chen, M.S. et al. Expression of multiple neuregulin transcripts in postnatal rat brains. J. Comp. Neurol. 349, 389-400 (1994). (Pubitemid 24328530)
13. Eilam, R., Pinkas-Kramarski, R., Ratzkin, B.J., Segal, M. & Yarden, Y. Activity-dependent regulation of Neu differentiation factor neuregulin expression in rat brain. Proc. Natl. Acad. Sci. USA 95, 1888-1893 (1998). (Pubitemid 28103489)
14. Woo, R.S. et al. Neuregulin-1 enhances depolarization-induced GABA release. Neuron 54, 599-610 (2007).
15. Wen, L. et al. Neuregulin 1 regulates pyramidal neuron activity via ErbB4 in parvalbumin-positive interneurons. Proc. Natl. Acad. Sci. USA 107, 1211-1216 (2010).
16. Neddens, J. & Buonanno, A. Selective populations of hippocampal interneurons express ErbB4 and their number and distribution is altered in ErbB4 knockout mice. Hippocampus 20, 724-744 (2010).
17. Fazzari, P. et al. Control of cortical GABA circuitry development by Nrg1 and ErbB4 signalling. Nature 464, 1376-1380 (2010).
18. Fisahn, A., Neddens, J., Yan, L.Q. & Buonanno, A. Neuregulin-1 modulates hippocampal gamma oscillations: implications for schizophrenia. Cereb. Cortex 19, 612-618 (2009).
19. Vullhorst, D. et al. Selective expression of ErbB4 in interneurons, but not pyramidal cells, of the rodent hippocampus. J. Neurosci. 29, 12255-12264 (2009).
20. McBain, C.J. & Fisahn, A. Interneurons unbound. Nat. Rev. Neurosci. 2, 11-23 (2001). (Pubitemid 33673345)
21. Markram, H. et al. Interneurons of the neocortical inhibitory system. Nat. Rev. Neurosci. 5, 793-807 (2004). (Pubitemid 39336216)
22. Pitcher, G.M. et al. Schizophrenia susceptibility pathway neuregulin 1-ErbB4 suppresses Src upregulation of NMDA receptors. Nat Med.
23. Ting, A.K. et al. Neuregulin 1 promotes excitatory synapse development and function in GABAergic interneurons. J. Neurosci. 31, 15-25 (2011).
24. Chen, Y.J. et al. ErbB4 in parvalbumin-positive interneurons is critical for neuregulin 1 regulation of long-term potentiation. Proc. Natl. Acad. Sci. USA.
25. Iyengar, S.S. & Mott, D.D. Neuregulin blocks synaptic strengthening after epileptiform activity in the rat hippocampus. Brain Res. 1208, 67-73 (2008).
26. Ozaki, M., Itoh, K., Miyakawa, Y., Kishida, H. & Hashikawa, T. Protein processing and releases of neuregulin-1 are regulated in an activity-dependent manner. J. Neurochem. 91, 176-188 (2004). (Pubitemid 39314948)
27. Backx, L., Ceulemans, B., Vermeesch, J.R., Devriendt, K. & Van Esch, H. Early myoclonic encephalopathy caused by a disruption of the neuregulin-1 receptor ErbB4. Eur. J. Hum. Genet. 17, 378-382 (2009).
28. Goddard, G.V., McIntyre, D.C. & Leech, C.K. A permanent change in brain function resulting from daily electrical stimulation. Exp. Neurol. 25, 295-330 (1969).
29. Racine, R.J. Modification of seizure activity by electrical stimulation. II. Motor seizure. Electroencephalogr. Clin. Neurophysiol. 32, 281-294 (1972).
30. Curia, G., Longo, D., Biagini, G., Jones, R.S. & Avoli, M. The pilocarpine model of temporal lobe epilepsy. J. Neurosci. Methods 172, 143-157 (2008).
31. Roysommuti, S., Carroll, S.L. & Wyss, J.M. Neuregulin-1beta modulates in vivo entorhinal-hippocampal synaptic transmission in adult rats. Neuroscience 121, 779-785 (2003). (Pubitemid 38367515)
32. Tidcombe, H. et al. Neural and mammary gland defects in ErbB4 knockout mice genetically rescued from embryonic lethality. Proc. Natl. Acad. Sci. USA 100, 8281-8286 (2003). (Pubitemid 36842536)
33. Bjarnadottir, M. et al. Neuregulin1 (NRG1) signaling through Fyn modulates NMDA receptor phosphorylation: differential synaptic function in NRG1r/f knock-outs compared with wild-type mice. J. Neurosci. 27, 4519-4529 (2007). (Pubitemid 46663586)
34. Gu, Z., Jiang, Q., Fu, A.K., Ip, N.Y. & Yan, Z. Regulation of NMDA receptors by neuregulin signaling in prefrontal cortex. J. Neurosci. 25, 4974-4984 (2005). (Pubitemid 40712840)
35. Li, B., Woo, R.S., Mei, L. & Malinow, R. The neuregulin-1 receptor ErbB4 controls glutamatergic synapse maturation and plasticity. Neuron 54, 583-597 (2007). (Pubitemid 46756136)
36. Chen, Q. et al. Differential roles of NR2A-and NR2B-containing NMDA receptors in activity-dependent brain-derived neurotrophic factor gene regulation and limbic epileptogenesis. J. Neurosci. 27, 542-552 (2007). (Pubitemid 46143758)
37. Bertram, E.H. & Cornett, J. The ontogeny of seizures in a rat model of limbic epilepsy: evidence for a kindling process in the development of chronic spontaneous seizures. Brain Res. 625, 295-300 (1993). (Pubitemid 23300426)
38. Stoll, S.W. et al. Differential utilization and localization of ErbB receptor tyrosine kinases in skin compared to normal and malignant keratinocytes. Neoplasia 3, 339-350 (2001). (Pubitemid 32801884)
39. Stevens, J.R. Epilepsy, psychosis and schizophrenia. Schizophr. Res. 1, 79-89 (1988).
40. Kido, H. & Yamaguchi, N. Clinical studies of schizophrenia-like state in epileptic patients. Jpn. J. Psychiatry Neurol. 43, 433-438 (1989). (Pubitemid 19279539)
41. Bruton, C.J., Stevens, J.R. & Frith, C.D. Epilepsy, psychosis, and schizophrenia: clinical and neuropathologic correlations. Neurology 44, 34-42 (1994). (Pubitemid 24029424)
42. Sachdev, P. Schizophrenia-like psychosis and epilepsy: the status of the association. Am. J. Psychiatry 155, 325-336 (1998). (Pubitemid 28114888)
43. Qin, P., Xu, H., Laursen, T.M., Vestergaard, M. & Mortensen, P.B. Risk for schizophrenia and schizophrenia-like psychosis among patients with epilepsy: population based cohort study. Br. Med. J. 331, 23 (2005).
44. Bob, P., Palus, M., Susta, M. & Glaslova, K. Sensitization, epileptic-like symptoms and local synchronization in patients with paranoid schizophrenia. Prog. Neuropsychopharmacol. Biol. Psychiatry 34, 143-146 (2010).
45. Cascella, N.G., Schretlen, D.J. & Sawa, A. Schizophrenia and epilepsy: is there a shared susceptibility? Neurosci. Res. 63, 227-235 (2009).
46. García-Rivello, H. et al. Dilated cardiomyopathy in Erb-b4-deficient ventricular muscle. Am. J. Physiol. Heart Circ. Physiol. 289, H1153-H1160 (2005). (Pubitemid 41208959)
47. Hippenmeyer, S. et al. A developmental switch in the response of DRG neurons to ETS transcription factor signaling. PLoS Biol. 3, e159 (2005).
48. Casanova, E. et al. A CamKII alpha iCre BAC allows brain-specific gene inactivation. Genesis 31, 37-42 (2001). (Pubitemid 32927797)
49. Casanova, E. et al. ER-based double iCre fusion protein allows partial recombination in forebrain. Genesis 34, 208-214 (2002). (Pubitemid 35334748)